Solstice Oncology, Inc. funding

Solstice Oncology, Inc., a biotechnology company based in Boston, MA (founded 2026), filed a Form D with the SEC on March 9, 2026 and reported $121M raised of a $298M offering.

Amount raised$121M

Offering size$298M

Filed with the SECMarch 9, 2026

First saleFebruary 20, 2026

IndustryBiotechnology

SecuritiesEquity, Options or warrants, Security to be acquired on exercise

LocationBoston, MA

Founded2026

Entity typeCorporation

Investors so far8

Minimum investment—

Revenue rangeDecline to Disclose

View the original Form D on SEC EDGAR ↗ · All rounds filed Mar 9

Other health care rounds in Massachusetts

Zai Lab Ltd$250M · Nov 9Biotechnology Typewriter Therapeutics, Inc.$56.3M · Sep 21Biotechnology AI3 Bio, Inc.$48.3M · Nov 4Biotechnology Nanopath Inc$29.9M · Nov 13Biotechnology XRHealth, Inc.$22.8M · Sep 16Other Health Care Xact Bio, Inc.$10M · Sep 28Biotechnology Crosslink Therapeutics Inc.$5.5M · Oct 20Pharmaceuticals Fresenius Medical Care Fulshear, LLC$4.4M · Oct 21Other Health Care